About this trial
Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subject with a NSCL/P or CL/P of unknown etiology,
national health care insurance holders
Disqualifiers
Subject with a CL/P of known etiology,
Subject with a NSCL/P and an IRF6 mutation
Trial design
Single group
Treatments tested in this trial
identification of genetic factors
GeneticClinical questionnaire and analysis of genetic data obtained by exome high-throughput sequencing
Treatment groups
Trial outcomes
Primary outcomes
Identification of genetic factors
Identification of genetic factors implicated in orofacial cleft using whole exome sequencing (WES).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.